A study protocol to characterise pathophysiological and molecular markers of rheumatic heart disease and degenerative aortic stenosis using multiparametric cardiovascular imaging and multiomics techniques.
Daniel W MutithuOlukayode O AremuDipolelo MokailaTasnim BanaMary FamilusiLaura TaylorLorna Jean MartinLaura J HeathfieldJennifer A KirwanLubbe WiesnerHenry A AdeolaEvelyn N LumngwenaRodgers ManganyiSebastian SkatullaRichard NaidooNtobeko A B NtusiPublished in: PloS one (2024)
In this cross-sectional, case-controlled study, we plan to recruit RHD and AS patients and compare them to matched controls. Living participants will undergo clinical assessment, echocardiography, CMR and blood sampling for circulatory biomarker analyses. Tissue samples will be obtained from patients undergoing valve replacement, while healthy tissues will be obtained from cadavers. Immunohistology, proteomics, metabolomics, and transcriptome analyses will be used to analyse circulatory- and tissue-specific biomarkers. Univariate and multivariate statistical analyses will be used for hypothesis testing and identification of important biomarkers. In summary, this study aims to delineate the pathophysiology of RHD and degenerative AS using multiparametric CMR imaging. In addition to discover novel biomarkers and explore the pathomechanisms associated with RHD and AS through high-throughput profiling of the tissue and blood proteome and metabolome and provide a proof of concept of the suitability of using cadaveric tissues as controls for cardiovascular disease studies.
Keyphrases
- aortic stenosis
- ejection fraction
- aortic valve
- cardiovascular disease
- left ventricular
- aortic valve replacement
- transcatheter aortic valve replacement
- high throughput
- transcatheter aortic valve implantation
- gene expression
- cross sectional
- patients undergoing
- high resolution
- single cell
- study protocol
- mass spectrometry
- end stage renal disease
- pulmonary hypertension
- newly diagnosed
- rheumatoid arthritis
- randomized controlled trial
- extracorporeal membrane oxygenation
- computed tomography
- rna seq
- type diabetes
- peritoneal dialysis
- clinical trial
- prognostic factors
- mitral valve
- coronary artery disease
- metabolic syndrome
- patient reported outcomes
- ultrasound guided
- data analysis
- open label
- dna methylation
- cardiovascular events
- patient reported
- label free
- photodynamic therapy
- atrial fibrillation